BioMarin is paying $270 million to acquire Inozyme Pharma. CRISPR Therapeutics announced an agreement with Sirius ...

In MM+M’s weekly C-Suite Scripts column, tastemakers from the pharma, biotech and medical marketing industries offer their ...

Startups are marketing AI products with lifelike voices to schedule or cancel medical visits, refill prescriptions, and help ...

When people call large insurance brokerages seeking free assistance in choosing Medicare Advantage plans, they’re often ...

The proposal also holds important clues — amid some mixed messages — about the administration’s approach to two pressing public health issues: mental health and addiction.